Active-ingredient Dossier
Naltrexone Hydrochloride
Active-ingredient Dossier for Naltrexone Hydrochloride (opioid antagonist). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: NALTREXONE
- Brand: ARX-NALTREXONE
- Brand: CONTRAVE
- Brand: NALTREXONE
- Brand: REVIATREXONE
- Therapeutic area: Psychiatry
- Therapeutic area: Endocrinology
What is
Naltrexone Hydrochloride Naltrexone Hydrochloride is an opioid antagonist.
Australian brands containing
Naltrexone Hydrochloride — NALTREXONE — ARX-NALTREXONE — CONTRAVE — NALTREXONE-APOTEX — REVIATREXONE
Therapeutic areas
Naltrexone Hydrochloride is registered in Pain & Anaesthesia (5 brands) and Endocrinology (1 brand).
Sponsor landscape
The ingredient is marketed by four sponsors: Arrotex Pharmaceuticals, Accord Healthcare, iNova Pharmaceuticals, and Generic Health.
PBS and regulatory activity
One brand containing naltrexone hydrochloride has PBS-listed items, with the latest PBS schedule date of 1 May 2026.